Recombinetics is a global leader in proprietary gene repair and gene-editing technology. Our breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing technologies has resulted in breakthroughs in the regenerative medicine, disease research and animal agriculture. Led by a team of expert geneticists, genome engineers, and reproductive physiologists, the company is headquartered in St. Paul, Minnesota.
Looking for a particular Recombinetics employee's phone or email?
Recombinetics Questions
The Recombinetics annual revenue was $25 million in 2026.
Rocco Morelli is the CEO of Recombinetics.
17 people are employed at Recombinetics.
Recombinetics is based in Eagan, Minnesota.
The NAICS codes for Recombinetics are [5417, 54, 54171, 541, 541714].
The SIC codes for Recombinetics are [873, 87].
Top Recombinetics Employees
-
Rocco Morelli
Chief Executive Officer at Recombinetics
Lincolnshire, IL, US35 -
Dan Carlson
Chief Scientific Officer at Recombinetics
Saint Paul, MN, US25+ -
Justin Zenanko
Chief Financial Officer at Recombinetics
Maple Plain, MN, US25+ -
Justin Zenanko
Chief Financial Officer at Recombinetics
Minneapolis, MN, US15 -
Bill Haupt
Director of Finance- Product and Innovation at Recombinetics
Saint Paul, MN, US55 -
Jarryd Campbell
Head of Platform Development at Recombinetics
Saint Paul, MN, US11 -
Dennis Webster
Research Associate at Recombinetics
Minneapolis, MN, US14 -
Derek Korpela
Research Scientist Recombinetics at Recombinetics
Bayport, MN, US11
Related Companies
